Graham Juan's Form 4 filing
Kyntra Bio, Inc.KYNB · filed Dec 15, 2022
- Accession no.
- 0001209191-22-061483
- Filed
- Dec 15, 2022
- Trade date
- Dec 8, 2022
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $85.5K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Graham JuanCIK 0001879223 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2022 | Common Stock | SSaleDisposed | −5,263 | $14.84F2 | −$78,102.92 | 50,628 | Direct | |
| Dec 8, 2022 | Common Stock | SSaleDisposed | −478 | $15.47 | −$7,394.66 | 50,150 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
These shares were sold in multiple transactions on the reported date with prices ranging from $14.38 to $15.355 resulting in a weighted average price of $14.84. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction.
Referenced by the price of 1 transaction in Table I.